TMO
Thermo Fisher Scientific Inc · Healthcare · Diagnostics & Research
TECHBuyZACKSBuy
R500#221 today
$654.80
+0.35% today · -2.99% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- TMO +0.35% on the last session vs SPY +0.74%: −0.4 pts of stock-specific move.
- Aftermath, big drop (Oct 1): After its 63 big drops in the past 5 years, TMO typically gained 0.3% over the next day (median) and was higher 57% of the time; half the outcomes fell between -0.9% and +1.5%. An ordinary day: -0.0%. Among S&P 500 stocks after big drops, that ranks #102 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Key facts
- Market cap
- $242.1B
- Held by institutions
- 94.0%
- Short interest
- 1.4%
- 52-week range
- 435.27–683.63
- Analyst mean target
- —
- Next earnings
- Oct 21 BMO
- Forward P/E
- 23.8
Recent events
Earnings ▲
2Q2026 results: EPS $6.03 vs $5.71 expected beat +$0.32 (+5.6%); revenue $12.0B; next session +8.7% (+9.9 vs SPY)Earnings ▲
1Q2026 results: EPS $5.44 vs $5.24 expected beat +$0.20 (+3.8%); revenue $11.0B; next session -9.2% (-8.8 vs SPY)Earnings ▲
4Q2025 results: EPS $6.57 vs $6.45 expected beat +$0.12 (+1.9%); revenue $12.2B; next session -2.6% (-2.4 vs SPY)Earnings ▲
3Q2025 results: EPS $5.79 vs $5.50 expected beat +$0.29 (+5.3%); revenue $11.1B; next session +1.6% (+2.2 vs SPY)